Clinical Research after COVID-19: Embracing a New Normal

The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelfand, Joel M., Hefele, Brooke E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466954/
https://www.ncbi.nlm.nih.gov/pubmed/32890628
http://dx.doi.org/10.1016/j.jid.2020.08.004
Descripción
Sumario:The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a COVID-19 new normal and adjust research procedures to mitigate the risk of transmitting severe acute respiratory syndrome coronavirus 2 and depleting personal protective equipment while maintaining scientific rigor.

Ejemplares similares